로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Antibody > Hemagglutinin (HA) > HA2-Y196

Monoclonal Anti-HA (Influenza A/Darwin/9/2021 (H3N2)) Antibody, Mouse IgG1 (1D6)

  • Source
    Monoclonal Anti-HA (Influenza A/Darwin/9/2021 (H3N2)) Antibody, Mouse IgG1 (1D6) antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Hemagglutinin (HA).
  • Isotype
    Mouse IgG1 | Mouse Kappa
  • Specificity
    This product is a specific antibody specifically reacts with Hemagglutinin (HA).
  • Application
    ELISA
  • Purity

    >95% as determined by SDS-PAGE.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.0 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20 to -70°C for 12 months in lyophilized state from date of receipt;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Hemagglutinin (HA) SDS-PAGE

Monoclonal Anti-HA (Influenza A/Darwin/9/2021 (H3N2)) Antibody, Mouse IgG1 (1D6) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

Bioactivity-Elisa
 Hemagglutinin (HA) ELISA

Immobilized Influenza A [A/Darwin/9/2021 (H3N2)] Hemagglutinin (HA) Protein, His Tag (MALS verified) (Cat. No. HA2-V52H6) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-HA (Influenza A/Darwin/9/2021 (H3N2)) Antibody, Mouse IgG1 (1D6)(Cat. No. HA2-Y196) with a linear range of 0.195-6.25 ng/mL (QC tested).

 Hemagglutinin (HA) ELISA

Immobilized Influenza A [A/Darwin/9/2021 (H3N2)] Hemagglutinin (HA) Protein, His Tag (MALS verified) (Cat. No. HA2-V52H6) can bind Monoclonal Anti-HA (Influenza A/Darwin/9/2021 (H3N2)) Antibody, Mouse IgG1 (1D6)(Cat. No. HA2-Y196). The antibody does not bind Influenza A [A/Bangkok/1/1979 (H3N2)] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA2-V52H3), Influenza A [A/Wisconsin/588/2019 (H1N1)] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA1-V52H3), Influenza A [A/Darwin/6/2021 (H3N2)] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA2-V52H5), Influenza A [Sydney/5/2021 (H1N1)] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA1-V52H4), Influenza B [Austria/1359417/2021 (B/Victoria lineage)] Hemagglutinin (HA) Protein, His Tag(Cat. No. HAE-V52H3), Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin 1 (HA1) Protein, His Tag (MALS verified)(Cat. No. HA1-V52H5), Influenza A [A/guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA2-V52H7) and Influenza A [A/Victoria/2570/2019] Hemagglutinin (HA) Protein, His Tag (MALS verified)(Cat. No. HA1-V52H6). (Routinely tested).

  • Background
    Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.
  • Clinical and Translational Updates

코멘트 (0)


재고상품 출발날짜: 영업일 기준 4일

가격(KRW) : 525,000

가격(KRW) : 3,465,000

보급 및 전시



약물 개발 현황

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 1 Clinical

Datasheet & Documentation

DMF 신청
DMF (Drug Master File)

신제품

문의와 컨텐츠

This web search service is supported by Google Inc.

totop